Long periods of viral suppression shown to prevent cancer in aging HIV population

June 11, 2018, American College of Physicians

Early, sustained antiretroviral therapy (ART), which results in long-term viral suppression, helps to prevent AIDS-defining cancers and also non-AIDS-defining cancers, to a lesser degree. However, patients with long-term viral suppression still had excess cancer risk compared to uninfected patients. The study, published in Annals of Internal Medicine, is the first to examine the effects of prolonged periods of viral suppression and potential cancer prevention benefits for the aging population of persons living with HIV.

Persons with HIV are at increased risk for AIDS-defining cancers (Kaposi sarcoma, non-Hodgkin lymphoma, ) and non-AIDS-defining cancers (lung, larynx, melanoma, leukemia, etc.). Some of these cancers are known to be caused by viruses (certain anal, liver, Hodgkin lymphoma, etc.) that are common among persons with HIV. Viral suppression is a key component of HIV treatment, and studies have shown an association between prolonged and decreased risk for some types of . However, no studies have specifically focused on the effect of sustained viral suppression on overall cancer risk.

Researchers from the Stanford Center for Population Health Sciences compared cancer rates for 42,441 HIV-positive veterans with those of 104,712 demographically-matched uninfected veterans from 1999-2015 to determine whether long-term viral suppression was associated with decreased cancer risk. They found that was highest in the unsuppressed state, lower in early suppression, lower still in long-term suppression, and lowest in uninfected patients for all cancer, AIDS-defining cancer, virus non-AIDS-defining-cancer, and several cancer types.

According to the authors, these findings are helpful to both infectious disease and clinicians who care for the population of aging HIV-positive patients. Understanding how HIV interacts with viral coinfections and results in higher risks of cancer may offer critical insight in how to better prevent and treat these cancers for everyone.

Explore further: By 2030, prostate and lung cancers expected to be most common cancers among HIV population

More information: Annals of Internal Medicine (2018). http://annals.org/aim/article/doi/10.7326/M16-2094

Related Stories

By 2030, prostate and lung cancers expected to be most common cancers among HIV population

May 7, 2018
Despite declines in cancer incidence rates among HIV-infected people, cancer will remain a significant concern as this patient population ages. By 2030, prostate and lung cancers are projected to be the most common cancers ...

Cancer burden may be changing for people living with HIV

April 5, 2017
The total number of cancer cases diagnosed among people living with the human immunodeficiency virus (HIV) is projected to decline in coming years, due mostly to declines in non-Hodgkin lymphoma and Kaposi sarcoma. Certain ...

Sustained viral suppression lower among blacks with HIV

February 6, 2018
(HealthDay)—A lower percentage of blacks than Hispanics and whites with HIV infection have sustained viral suppression, according to research published in the Feb. 2 issue of the U.S. Centers for Disease Control and Prevention's ...

Cancer burden shifts for people with HIV/AIDS

April 11, 2011
The number of cancers and the types of cancers among people living with AIDS in the U.S. have changed dramatically during the 15-year period from 1991-2005, according to an article published online April 11th in the Journal ...

ART era has changed secondary cancers after Kaposi sarcoma

August 25, 2017
(HealthDay)—There has been a significant decline in the risk of secondary cancers after Kaposi sarcoma (KS) in the era of highly-active antiretroviral therapy (HAART), according to a study published online Aug. 24 in JAMA ...

Recommended for you

Researchers artificially generate immune cells integral to creating cancer vaccines

August 14, 2018
For the first time, Mount Sinai researchers have identified a way to make large numbers of immune cells that can help prevent cancer reoccurrence, according to a study published in August in Cell Reports.

Chemicals found in vegetables prevent colon cancer in mice

August 14, 2018
Chemicals produced by vegetables such as kale, cabbage and broccoli could help to maintain a healthy gut and prevent colon cancer, a new study from the Francis Crick Institute shows.

Ovarian cancer genetics unravelled

August 14, 2018
Patterns of genetic mutation in ovarian cancer are helping make sense of the disease, and could be used to personalise treatment in future.

Lymphatic vessels unexpectedly promote the spread of cancer metastases

August 14, 2018
Lymphatic vessels actively contribute to the spread of cancer metastases from various organs. This unexpected realisation is the result of a joint study by researchers from ETH Zurich and the University Hospital Zurich as ...

Stress hormone is key factor in failure of immune system to prevent leukemia

August 14, 2018
The human stress hormone cortisol has been identified by scientists at the University of Kent as a key factor when the immune system fails to prevent leukemia taking hold.

Medically underserved women in the Southeast rarely receive BRCA tests

August 14, 2018
Medically underserved women in the Southeast diagnosed with breast cancer or ovarian cancer missed out on genetic testing that could have helped them and their relatives make important decisions about their health, according ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.